BEGIN:VCALENDAR VERSION:2.0 PRODID:-//wp-events-plugin.com//7.4.3//EN TZID:Europe/Berlin X-WR-TIMEZONE:Europe/Berlin BEGIN:VEVENT UID:276@ern-lung.eu DTSTART;TZID=Europe/Berlin:20260417T000000 DTEND;TZID=Europe/Berlin:20260418T000000 DTSTAMP:20260205T091842Z URL:https://ern-lung.eu/events/5th-national-congress-on-sarcoidosis-diagno sis-and-treatment/ SUMMARY:5th National Congress on Sarcoidosis Diagnosis and Treatment DESCRIPTION:17-18 April 2026\n\nThe ACSI (Friends Against Sarcoidosis Italy ) Association and its President dr Filippo Martone are pleased to announce the\n\nFIFTH NATIONAL CONFERENCE ON SARCOIDOSIS DIAGNOSIS AND TREATMENT: Evolution and new paradigms.\n\nSarcoidosis is a rare\, chronic\, systemic granulomatous inflammatory disease characterised by high clinical heterog eneity. It can be asymptomatic\, constituting an incidental diagnostic fin ding\, or it can manifest with multi-organ involvement and a chronic cours e\, often associated with pre-existing or time-dependent comorbidities.\nA significant proportion of patients – estimated between 30% and 50% – present complex forms\, burdened by a high morbidity load\, determined not only by the direct manifestations of the disease\,\nbut also by the prese nce of concomitant or emerging comorbidities and the side effects of prolo nged therapies\, particularly those based on corticosteroids and immunosup pressants.\nThese conditions have a significant impact on patients’ qual ity of life\, with important psychosocial repercussions and reduced workin g capacity\, which also translate into significant socio-economic costs\nD espite advances in research\, sarcoidosis remains a largely “orphan” d isease: little known\, often underestimated in its severity and sometimes mistakenly considered a benign and self-limiting condition. This perceptio n contributes to diagnostic delays\, inadequate treatment and fragmented m anagement that is not commensurate with the clinical complexity of patient s.\nThe systemic nature of the disease\, together with the frequent presen ce of comorbidities\, requires an integrated and multidisciplinary clinica l approach\, which can only be achieved in reference centres with specific expertise\, adequate resources and a strong involvement in scientific res earch and the development of new therapeutic options.\nIn recent years\, s arcoidosis has received increasing attention thanks to the joint efforts o f national European patient associations\, leading international scientifi c societies (WASOG\, ELF\, ERS) and supranational organisations affiliated with the European Commission\, such as the ERN Lung Sarcoidosis Core Netw ork\, which are working to accelerate research and redefine diagnostic and therapeutic paradigms.\nThis is the context for the 5th National Congress on the Diagnosis and Treatment of Sarcoidosis – “Evolution and New Pa radigms”\, which represents an important opportunity for multidisciplina ry discussion to explore the many aspects of the disease. Thanks to the co ntribution of authoritative national and international experts\, the main clinical and management aspects of sarcoidosis will be discussed\, with pa rticular attention to technological innovation\, quality of life\, the psy chosocial dimension and the psychological care of patients.\nThe aim is to promote an increasingly in-depth understanding of sarcoidosis\, its etiop athogenetic mechanisms and its manifestations\, in order to improve the di agnostic-therapeutic approach\,\nenhance care and progress towards a defin itive cure.\n\nCheck out the Congress poster ATTACH;FMTTYPE=image/jpeg:https://ern-lung.eu/wp-content/uploads/2026/02/S arcoidosis-Congress-Visual-Inglese-2026.jpg CATEGORIES:Sarcoidosis LOCATION:https://www.sarcoidosi.org/quinto-congresso-nazionale-sulla-diagno si-e-cura-della-sarcoidosi/ END:VEVENT BEGIN:VTIMEZONE TZID:Europe/Berlin X-LIC-LOCATION:Europe/Berlin BEGIN:DAYLIGHT DTSTART:20260329T030000 TZOFFSETFROM:+0100 TZOFFSETTO:+0200 TZNAME:CEST END:DAYLIGHT END:VTIMEZONE END:VCALENDAR